AG

Adam Gazzaley

Founder & Executive Director of Neuroscape at UCSF; Co-Founder, Board Member & Chief Science Advisor at Akili and JAZZ VP

San Francisco, California

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2005

  • Professor of Neurology, Psychiatry and Physiology

    2005

  • Executive Director, Neuroscape

    2017

    Neuroscape is a translational neuroscience center at UCSF engaged in technology creation and scientific research to better assess and optimize brain function of both healthy and impaired individuals.

  • Co-Founder and Chief Science Advisor

    2011

    At Akili, we're in the process of building clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like high-quality video games. Our aim is to develop a new type of Electronic Medicine™ that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches

  • Co Founder and Chief Scientist

    2015

    JAZZ Venture Partners invests in experiential technologies (XTech) that improve human performance -- emerging companies leveraging the convergence of new digital technology platforms (e.g. virtual and augmented reality, immersive videogaming, artificial intelligence, deep learning, brain-computer interfaces, robotics) with recent advances in neuroscience that are creating entirely new ways to improve the human experience. These companies are impacting multiple $100+ billion industries including health, mind-body wellness, peak mental and physical acuity, accelerated learning and training, sports, and entertainment.

2018 - 2021

  • Co-Founder and Chief Science Advisor

    2018 - 2021